North America Non-energy Based Aesthetic Treatment Market (2023 - 2030) Size, Share & Trends Analysis Report By Procedures (Injectables, Skin Rejuvenation), By End-use, By Region, And Segment Forecasts

Report Overview

The North America non-energy Based aesthetic treatment market size was valued at USD 16.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 13.9% from 2023 to 2030. The growing awareness among people about aesthetic appeal and technological advancements in aesthetic treatment are the factors propelling the market growth. The increasing prevalence of skin conditions and the rising geriatric population contributes largely to the high demand for non-invasive aesthetic treatment. A rise in disposable income is also considered one of the important factors driving the market growth of non-invasive aesthetic treatment. Minimally invasive surgeries are rapidly replacing invasive surgeries.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

According to the International Society of Aesthetic Plastic Surgery (ISAPS), 13,618,735 non-invasive procedures were performed globally in 2019, with 2,630,832 procedures being performed in the U.S. alone. The onset of COVID-19 acted as a springboard for non-invasive aesthetic treatments as the market witnessed higher demand for the treatments like fillers, Botox, and skin lasers to look appealing on Zoom calls & meetings. During the pandemic, Botox and soft-tissue fillers have remained the most popular minimally invasive procedures in the U.S.

In a survey of plastic surgeons by ASPS, 55.0% of surgeons stated that Botox injections were the most frequently desired treatment, while the stay-at-home mandate has been in effect. A new trend in aesthetics is the growing demand to look appealing on virtual video-calling platforms during meetings and conferences.

Noninvasive aesthetic procedures offer advantages, including shorter downtime, less pain & surgical wounds, smaller incisions, rapid wound healing, and fewer complications than invasive surgeries. Moreover, minimally invasive surgeries are more effective and provide better outcomes than conventional surgical treatments.

The introduction of various insurance schemes for aesthetic and cosmetic procedures has contributed to the increase in this market's awareness, acceptance, and growth. For instance, the U.K.-based insurance company Hamilton Fraser is specifically dedicated to providing insurance for a broad range of aesthetic procedures, including laser treatments, dermal fillers, chemical peels, and botulinum toxin.

Social media has played a vital role in influencing the purchasing decisions by millennials; peer recommendation carries much importance when it comes to purchasing. According to 2019 Hubspot data, 71% of people are more likely to purchase a product or service online when others recommend it. Moreover, a small group of influencers is responsible for the largest share of referral branding via social media.

Procedure Insights

The injectables segment held the largest share of more than 85.1% in 2022 and is also anticipated to expand at a healthy CAGR of 14.1% from 2023 to 2030. This can be attributed to the fact that it is the most highly adopted procedure globally. The U.S. has a large procedural volume of botulinum toxin and hyaluronic acid fillers. According to the International Society of Aesthetic Plastic Surgery, around 10,610,748 injectable procedures were carried out globally, which included botulinum toxin fillers, hyaluronic acid fillers, calcium hydroxyl apatite, and Poly-L-Lactic Acid fillers in 2020.

The skin rejuvenation segment is expected to witness a lucrative growth rate of 13.4% during the forecast period. Botulinum toxin is the most popular filler in noninvasive aesthetic treatments. Currently, a few products of BNT-A and only one product of BNT-B are commercially available in the market. However, high R&D investments to expand the aesthetic applications of BNT are anticipated to boost the market soon.

End-Use Insights

Med spa forms the largest end-user, with a share of around 34.5% in 2022. This dominion can be attributed to the fact that med spas of aesthetic clinics are the facilities wherein cosmetic treatments are administered under the supervision of a licensed physician. Med spas are generally a combination of aesthetic medical centers and day spas that offer corrective medical skin care treatments and products. The average med spa earns more than USD 1.0 million a year, according to the Am Spa 2019 Medical Spa State of the Industry Report.

To learn more about this report, Download Free Sample Report

The traditional spa segment is expected to witness lucrative growth of 14.6% during the forecast period. SBDC Net National Information Clearinghouse states that the U.S. has around 77,000 beauty salons. Factors such as demographics, population growth, and increasing personal income boost the country’s market. Effective marketing and repeat business are the major factors driving the profitability of traditional spas. The same source stated that 50 large beauty salon operators generate about 15.0% of U.S. industry revenue.

Regional Insights

The U.S. is the predominant region for the North America non-energy-based aesthetic treatment market, with a share of 85.3% in 2022. The increasing prevalence of skin cancer & other skin diseases, such as eczema & rosacea, and the growing adoption of cosmetic procedures are some of the major factors contributing to the market growth in this region. Moreover, easy availability and increasing adoption of advanced treatment options, such as laser treatments to enhance one's aesthetic appeal, are expected to boost the market.

Canada is expected to witness a lucrative growth rate of 13.4% during the forecast period. According to Global News, nearly one in every five women in Canada is dissatisfied with their appearance. High healthcare expenditure and advanced facilities are the key factors fueling the growth of Canada's non-invasive aesthetic treatment market. Moreover, the country lags behind other developed and developing economies with regard to the number of aesthetic surgeons & professionals and accounts for only 1.0% (500) of the total plastic surgeons globally.

Key Companies & Market Share Insights

Several market leaders are acquiring smaller players to strengthen their market position. This strategy enables them to increase their capabilities, expand their product portfolios, and improve their competencies. Other key layers are focused on partnerships, mergers, and acquisitions will allow them to introduce new products in different markets.

In January 2022, Galderma acquired ALASTIN Skincare, a specialty products company aiming to develop innovative and clinically-tested physician-dispensed skincare products. Some of the prominent players in the North America non-energy Based aesthetic treatment market include:

• Allergan plc. (AbbVie)

• Galderma

• Merz Pharma

• LPG SYSTEMS

• NeoGenesis, Inc.

• Oxygenceuticals

• Genesis Biosystems, Inc.

• Revance Therapeutics, Inc.

• Ipsen Pharma

• Sun Eva Medical, Inc.

• Mesoestetic Pharma Group SL

North America non-energy Based aesthetic Treatment Market Segmentation

This report forecasts revenue growth at regional and country levels in addition to provide an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the North America non-energy Based aesthetic treatment market report based on the procedure, end-use, and region:

To learn more about this report, Download Free Sample Report

• Procedure Outlook (Revenue, USD Million, 2018 - 2030)

  • Injectables

    • Botulinum Toxin

    • Calcium Hydroxyl Apatite

    • Hyaluronic Acid

    • Polymer Filler

    • Collagen

  • Skin Rejuvenation

    • Chemical Peel

    • Microdermabrasion

    • Micro Needling
      

• End-Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospital/Surgery Center

  • Med Spa

  • Traditional Spa

  • HCP Owned Clinic

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada